170 related articles for article (PubMed ID: 22648778)
1. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application.
Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL
Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778
[TBL] [Abstract][Full Text] [Related]
2. Animal models for prenatal gene therapy: the sheep model.
Abi-Nader KN; Boyd M; Flake AW; Mehta V; Peebles D; David AL
Methods Mol Biol; 2012; 891():219-48. PubMed ID: 22648775
[TBL] [Abstract][Full Text] [Related]
3. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
[TBL] [Abstract][Full Text] [Related]
5. The sheep model of in utero gene therapy.
Porada CD; Park P; Almeida-Porada G; Zanjani ED
Fetal Diagn Ther; 2004; 19(1):23-30. PubMed ID: 14646413
[TBL] [Abstract][Full Text] [Related]
6. Animal models for prenatal gene therapy: the nonhuman primate model.
Mattar CN; Biswas A; Choolani M; Chan JK
Methods Mol Biol; 2012; 891():249-71. PubMed ID: 22648776
[TBL] [Abstract][Full Text] [Related]
7. Fetal muscle gene therapy/gene delivery in large animals.
Abi-Nader KN; David AL
Methods Mol Biol; 2011; 709():239-56. PubMed ID: 21194032
[TBL] [Abstract][Full Text] [Related]
8. Monitoring for potential adverse effects of prenatal gene therapy: mouse models for developmental aberrations and inadvertent germ line transmission.
Coutelle C; Waddington SN; Themis M
Methods Mol Biol; 2012; 891():329-40. PubMed ID: 22648779
[TBL] [Abstract][Full Text] [Related]
9. Animal models for prenatal gene therapy: choosing the right model.
Mehta V; Peebles D; David AL
Methods Mol Biol; 2012; 891():183-200. PubMed ID: 22648773
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
[TBL] [Abstract][Full Text] [Related]
11. Organ targeted prenatal gene therapy--how far are we?
Mehta V; Abi Nader K; Waddington S; David AL
Prenat Diagn; 2011 Jul; 31(7):720-34. PubMed ID: 21618255
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for the fetus: is there a future?
David AL; Peebles D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):203-18. PubMed ID: 17900991
[TBL] [Abstract][Full Text] [Related]
13. On the scientific and ethical issues of fetal somatic gene therapy.
Coutelle C; Rodeck C
Gene Ther; 2002 Jun; 9(11):670-3. PubMed ID: 12032684
[TBL] [Abstract][Full Text] [Related]
14. Candidate diseases for prenatal gene therapy.
David AL; Waddington SN
Methods Mol Biol; 2012; 891():9-39. PubMed ID: 22648766
[TBL] [Abstract][Full Text] [Related]
15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
16. Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization.
Fazio VM; Ria F; Franco E; Rosati P; Cannelli G; Signori E; Parrella P; Zaratti L; Iannace E; Monego G; Blogna S; Fioretti D; Iurescia S; Filippetti R; Rinaldi M
Gene Ther; 2004 Mar; 11(6):544-51. PubMed ID: 14999226
[TBL] [Abstract][Full Text] [Related]
17. Vector systems for prenatal gene therapy: principles of non-viral vector design and production.
Wong SP; Argyros O; Harbottle RP
Methods Mol Biol; 2012; 891():133-67. PubMed ID: 22648771
[TBL] [Abstract][Full Text] [Related]
18. The concept of prenatal gene therapy.
Coutelle C; Waddington SN
Methods Mol Biol; 2012; 891():1-7. PubMed ID: 22648765
[TBL] [Abstract][Full Text] [Related]
19. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
